发明名称 |
CELL THERAPY |
摘要 |
Dextran sulfate is used in order to reduce pulmonary uptake of intravenously injected Dextran sulfate is capable of reducing the pulmonary uptake of the intravenously injected cells to the levels obtained for intraarterial injection of the cells but without the accompanying risks and side effects of using intraarterial cell injection. The dextran sulfate can therefore be used in a composition together with tumor infiltrating T-lymphocytes to treat metastatic cancer in a subject. |
申请公布号 |
EP2593113(A4) |
申请公布日期 |
2015.08.05 |
申请号 |
EP20110807152 |
申请日期 |
2011.07.08 |
申请人 |
TX MEDIC AB |
发明人 |
KORSGREN, OLLE;NILSSON, BO |
分类号 |
A61K31/737;A61K35/12;A61P35/04 |
主分类号 |
A61K31/737 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|